Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2018.280 | A cross sectional study to assess the effect of androgen deprivation therapy on Gut and Urinary Microbiota in patients with prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2018.541 | SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 multi-institution randomized prospective clinical trial evaluating the impact of cytoreductive radical prostatectomy combined with best systemic therapy on oncologic and quality of life outcomes in men with newly diagnosed metastatic prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2020.611 | To identify potential new urine marker panel for cancer screening |
Prof. NG Chi Fai 吳志輝 |
| 2019.662 | The use of REZUM system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2020.603 | To investigate the role of gut microbiome in androgen deprivation therapy related metabolic changes in prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2019.378 | To identify potential new genetic marker for diagnosis of cystinuria. |
Prof. NG Chi Fai 吳志輝 |
| 2021.687 | Surgical PRODUCT SURVEILLANCE REGISTRY (PSR) PLATFORM BASE & Medtronic Hugo™ RAS System General Surveillance in Hong Kong Product Surveillance Registry (PSR) Platform Analysis Plan |
Prof. NG Chi Fai 吳志輝 |
| 2023.085 | Association between nephrolithiasis and future cardiovascular events: a population-based analysis of patients utilizing public health systems in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2023.084 | Clinical Characteristics, Anticholinergic Burden, Treatment Patterns, and Drug Persistence in Patients with Overactive Bladder in Hong Kong: A Real-World Observational Study |
Prof. NG Chi Fai 吳志輝 |
| 2021.675 | Development of luminescent nanobiosensor for bladder cancer miRNA detection |
Prof. NG Chi Fai 吳志輝 |
| 2022.244 | The use of temporarily implanted nitinol device (iTind) system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2021.684 | A prospective assessment of the perioperative parameter and treatment outcomes of urinary calculi in Hong Kong |
Prof . NG Chi Fai 吳志輝 |
| 2023.509 | To investigate the effect of multidisciplinary care approach on cardiovascular risk modification in prostate cancer patients receiving androgen deprivation therapy |
Prof. NG Chi Fai Chi Fai NG |
| 2021.506 | To investigate the effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the treatment of stress urinary incontinence compared with standard of care in Chinese men who had undergone robotic radical prostatectomy | Prof. NG Chi Fai |
| 2023.172 | A prospective assessment of the perioperative parameter and treatment outcomes of Endoscopic Combined Intrarenal Surgery (ECIRS) in Asia |
Prof. NG Chi Fai 吳志輝 |
| 2022.301 | A study to evaluate patient and physician benefit/ risk preferences for treatment of metastatic prostate cancer (mPC) in Hong Kong: a discrete choice experiment |
Prof NG Chi Fai 吳志輝 |
| 2021.492 | A survey to investigate possible factors that will affect the choice of androgen deprivation therapy in prostate cancer patients |
Prof NG Chi Fai 吳志輝 |
| 2021.484 | Randomized, Open-label, Phase 3 Study of Acapatamab vs Standard of Care in Metastatic Castration-resistant Prostate Cancer (CAPTIVATE) |
Prof. NG Chi Fai 吳志輝 |
| 2023.180 | Retrospective, Non-interventional Study Assessing the Real-Life Use of The Long-Acting Gonadotropin-releasing Hormone Agonist as A Treatment for Locally Advanced or Metastatic Prostate Cancer in Hong Kong. |
Prof. NG Chi Fai 吳志輝 |
| 2024.114 | Surveys to investigate injection site complications and pain related to androgen deprivation therapies in prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2022.082 | DAROL: Darolutamide Observational Study in non-metastatic castration-resistant prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2022.093 | Exploring multiomics biomarkers for urolithiasis |
Prof. NG Chi Fai 吳志輝 |
| 2022.645 | To linguistically and psychometrically validate the Hong Kong Chinese version of the BPH 3-item questionnaire | Prof. NG Chi Fai |
| 2022.560 | To study the effect of baseline testosterone level on prognosis in Asian patients with prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2023.583 | A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma | Prof. NG Chi Fai |
| 2022.576 | A retrospective study of the urinary stone composition and its epidemiological and clinical association in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2022.158 | The prevalence of Iron deficiency in Advanced Prostate Cancer Patients with Anaemia and the Impact on Patients |
Prof. NG Chi Fai 吳志輝 |
| 2022.051 | A territory-wide retrospective study comparing the effects of different types of androgen deprivation therapy on cardiovascular disease of prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2023.589 | Performance, Feasibility, and Safety Study for a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours: First-In-Human Trial | Prof. NG Chi Fai |
| 2022.049 | A prospective assessment of the perioperative parameter and treatment outcomes of surgical treatment for benign prostate hyperplasia in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2021.650 | Surgery by the Medtronic Hugo™ Robotic System: A Prospective Single Centre Study |
Prof. NG Chi Fai 吳志輝 |
| 2022.394 | Elucidating the functional role of exosomal protein LRG1 and its clinical implication in castration-resistant prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2021.652 | TFL vs Ho:YAG – A prospective study to compare the effectiveness of Thulium Fiber laser and Holmium YAG laser for ureteroscopic lithotripsy |
Prof. NG Chi Fai 吳志輝 |
| 2022.046 | To understand the role of spermine on prostate cancer and its potential therapeutic application |
Prof. NG Chi Fai 吳志輝 |
| 2022.182 | A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
Prof. NG Chi Fai 吳志輝 |
| 2013.493 | A Double-blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Effectiveness of Cook MyoSite Incorporated AMDC in Female Patients with Stress Urinary Incontinence | Prof Ng Chi Fai |
| 2014.096 | A prospective study to investigate the effect of stepwise voltage escalation on treatment outcome in extracorporeal shockwave lithotripsy of renal calculi | Prof. Ng Chi Fai |
| 2009.620 | Strategies To Prevent Renal Trauma | Prof. Ng Chi Fai |
| 2010.507 | The role of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia. | Prof. Ng Chi Fai |
| 2013.494 | PROSPER: A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | Prof. NG Chi Fai |
| 2011.375 | A prospective randomized double-blinded placebo controlled study on the effects of shockwave therapy in patients suffered erectile dysfunction | Prof. Ng Chi Fai |
| 2013.536 | A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder | Prof. NG Chi Fai |
| 2014.214 | A longitudinal study on the outcome of male voiding dysfunction in Hong Kong Chinese Male | Prof. NG Chi Fai |
| 2010.494 | A prospective study to investigate the effect of different treatment protocols on renal injury during extracorporeal shockwave lithotripsy | Prof. Ng Chi Fai |
| 2012.105 | ADJUVANT AXITINIB TREATMENT OF RENAL CANCER: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF ADJUVANT AXITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RCC | Prof. NG Chi Fai |
| 2009.333 | The impact of 60 verse 120 shock wave per minute on treatment outcome, renal injury and patients | Prof. Ng Chi Fai |
| 2012.399 | Health Exhibition Health Check Survey | Prof. Ng Chi Fai |
| 2012.316 | The pattern of presentation of Chinese diagnosed with prostate cancer | Prof Ng Chi Fai |
| 2010.465 | A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Chemotherapy-Na_ve Metastatic Castration-Resistant Prostate Cancer | Professor Ng Chi Fai |
| 2010.577 | Prospective study of the effect of androgen deprivation therapy (ADT) in male patients suffered prostate cancer in Chinese Population | Prof. NG Chi Fai |
Page 171 of 254.